Drug intelligence / Profile preview

(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine

Development stage: Unknown
Modality: Small Molecules

Overview

This compound is a small molecule heterocyclic organic compound with the formula C10H14N2OS. It is classified as an alkyl aryl ether and features a thienoxazepine core structure. The molecule has been studied in structural biology contexts and is known to bind to the oxygenase domain of human endothelial nitric oxide synthase (eNOS/NOS3), acting as an inhibitor in crystallographic studies. Its primary use appears to be experimental and research-based rather than clinical or therapeutic at this time. No approved medical indications or marketed formulations are reported for this compound[1][4][5].

Other names: (3S)-3-propyl-2H,3H-thieno[2,3-f][1,4]oxazepin-5-amineThieno[2,3-f]-1,4-oxazepin-5(2H)-imine, 3,4-dihydro-3-propyl-, (3S,5E)-

Targets

NOS3 (eNOS)

Beyond the preview

Go deeper on (3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine.

Explore the full profile